Program Director Beth Clayton explains how Accuro improves epidural efficacy, reduces complications, and enhances the overall patient experience.
Recent Posts
- 32% Cesarean Rate Drives Demand for First-Attempt Neuraxial Success
- Solving the Blind Procedure Problem in Modern Obstetric Anesthesia
- RIVANNA’s 2025 Year in Review: Medical Imaging Innovation Across U.S. Healthcare
- Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes
- RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit